Payoneer Solution to inflammatory skin diseases
We solve autoimmune skin inflammatory diseases such as Psoriasis using innovative solutions.
About
I Derm Pharma is a biotechnology company focused on developing a first-in-class Oral therapy, for treating autoimmune inflammatory skin diseases such as Psoriasis.
About 2-3% of the world's population suffers from Psoriasis. This chronic, painful, disabling, incurable skin disease negatively impacts patients’ quality of life, including physical, functional, and emotional well-being. .
Existing treatment options for moderate-to-mild patients, including oral therapies and biologics, have notable limitations:
-
Oral therapies - Existing Oral therapies show limited efficacy or reduced safety, which can lead to severe side effects, toxicity, and require continuous monitoring.
-
Biologics are effective but expensive, pose risks of long-term side effects, and their efficacy can diminish over time.
This underscores the unmet need for a new class of safe, effective, user-friendly, and cost-efficient oral treatments with a favorable tolerability profile.
Our Solution
At I Derm Pharma, we have developed a proprietary small molecule therapy that introduces a first-in-class mechanism of action. This groundbreaking approach targets a novel pathway within the local skin's inflammatory pathway, effectively modulating inflammation without compromising the immune system.
Our oral solution combines enhanced safety, low toxicity with high efficacy, offering the convenience of oral administration to address challenges associated with biologic injections.
